Skip to Content

Workers’ Compensation Board

Search menu

The majority of online services should now be restored. Users may still experience lingering issues with some applications. Prior Authorization Request due dates have been extended to July 22nd. Digital Notices are now available.

Due to planned OnBoard maintenance occurring between 2:00 a.m. to 5:00 a.m. ET on Monday, July 22, 2024, and between 2:00 a.m. to 2:30 a.m. ET on Tuesday, July 23, 2024, email and text notifications may not be generated during this period. Please check your dashboards for prior authorization requests (PARs) and PAR responses submitted during this period. All other functionality will be working, including updates to the electronic case folders in eCase.

Subject Number 046-1012 Board Announces Draft Regulations for New York State Pharmacy Formulary

Board Bulletins and Subject Numbers

December 28, 2017

The New York State Workers' Compensation Board (Board) invites public comment on a proposed Pharmacy Formulary.

Governor Cuomo signed into law in April 2017 legislation that required the Board to establish a comprehensive prescription drug formulary by December 31, 2017. Therefore, the Board is announcing the establishment and release of the proposed formulary and is seeking public comments. Publication in the State Register on December 27, 2017 commences a 60-day comment period (which expires on February 26, 2018). The draft formulary and the associated regulations necessary for implementation are available on the Board's website.

The current draft proposes a July 1, 2018 effective date. However, the drug formulary and regulations will not become effective until the regulations are adopted and a final implementation date has been determined.

Anyone interested in commenting must submit their comments on or before February 26, 2018. This includes requests to add/delete pharmaceuticals to the preferred list of the prescription drug formulary. The Board will evaluate all comments received, and will consider necessary revisions as the process advances.

The Board is committed to the successful implementation of the Prescription Drug Formulary.

We look forward to receiving your comments.

Clarissa M. Rodriguez